215 related articles for article (PubMed ID: 33253517)
41. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
[TBL] [Abstract][Full Text] [Related]
42. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
[TBL] [Abstract][Full Text] [Related]
43. Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcinoma.
Zhao X; Cao D; Ren Z; Liu Z; Lv S; Zhu J; Li L; Lang R; He Q
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32701143
[TBL] [Abstract][Full Text] [Related]
44. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer.
Wang W; Lou W; Ding B; Yang B; Lu H; Kong Q; Fan W
Aging (Albany NY); 2019 May; 11(9):2610-2627. PubMed ID: 31061236
[TBL] [Abstract][Full Text] [Related]
45. Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma.
Zheng X; Liu X; Zheng H; Wang H; Hong D
Int Immunopharmacol; 2021 Jan; 90():106982. PubMed ID: 33129696
[TBL] [Abstract][Full Text] [Related]
46. Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network.
Zhao D; Ren C; Yao Y; Wang Q; Li F; Li Y; Jiang A; Wang G
J Cell Biochem; 2020 Mar; 121(3):2437-2446. PubMed ID: 31692050
[TBL] [Abstract][Full Text] [Related]
47. Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma.
Xu D; Wang Y; Liu X; Zhou K; Wu J; Chen J; Chen C; Chen L; Zheng J
Pharmacol Res; 2021 Feb; 164():105370. PubMed ID: 33316381
[TBL] [Abstract][Full Text] [Related]
48. Screening key genes and miRNAs in early-stage colon adenocarcinoma by RNA-sequencing.
Liu J; Liu F; Li X; Song X; Zhou L; Jie J
Tumour Biol; 2017 Jul; 39(7):1010428317714899. PubMed ID: 28714374
[TBL] [Abstract][Full Text] [Related]
49. Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis.
Rajamani D; Bhasin MK
Genome Med; 2016 May; 8(1):38. PubMed ID: 27137215
[TBL] [Abstract][Full Text] [Related]
50. Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?
Previdi MC; Carotenuto P; Zito D; Pandolfo R; Braconi C
Future Oncol; 2017 Feb; 13(5):443-453. PubMed ID: 27841659
[TBL] [Abstract][Full Text] [Related]
51. A machine learning approach identified a diagnostic model for pancreatic cancer through using circulating microRNA signatures.
Alizadeh Savareh B; Asadzadeh Aghdaie H; Behmanesh A; Bashiri A; Sadeghi A; Zali M; Shams R
Pancreatology; 2020 Sep; 20(6):1195-1204. PubMed ID: 32800647
[TBL] [Abstract][Full Text] [Related]
52. Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles.
Yerukala Sathipati S; Ho SY
Sci Rep; 2017 Aug; 7(1):7507. PubMed ID: 28790336
[TBL] [Abstract][Full Text] [Related]
53. An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers.
Robles AI; Arai E; Mathé EA; Okayama H; Schetter AJ; Brown D; Petersen D; Bowman ED; Noro R; Welsh JA; Edelman DC; Stevenson HS; Wang Y; Tsuchiya N; Kohno T; Skaug V; Mollerup S; Haugen A; Meltzer PS; Yokota J; Kanai Y; Harris CC
J Thorac Oncol; 2015 Jul; 10(7):1037-48. PubMed ID: 26134223
[TBL] [Abstract][Full Text] [Related]
54. Integrating high-throughput microRNA and mRNA expression data to identify risk mRNA signature for pancreatic cancer prognosis.
Wang P; Li W; Zhai B; Jiang X; Jiang H; Zhang C; Sun X
J Cell Biochem; 2020 Jun; 121(5-6):3090-3098. PubMed ID: 31886578
[TBL] [Abstract][Full Text] [Related]
55. Integration analysis for novel lncRNA markers predicting tumor recurrence in human colon adenocarcinoma.
Chen F; Li Z; Deng C; Yan H
J Transl Med; 2019 Aug; 17(1):299. PubMed ID: 31470869
[TBL] [Abstract][Full Text] [Related]
56. Prognostic DNA methylation markers for prostate cancer.
Strand SH; Orntoft TF; Sorensen KD
Int J Mol Sci; 2014 Sep; 15(9):16544-76. PubMed ID: 25238417
[TBL] [Abstract][Full Text] [Related]
57. In Silico Analysis of Gene Expression Change Associated with Copy Number of Enhancers in Pancreatic Adenocarcinoma.
Kumar R; Patiyal S; Kumar V; Nagpal G; Raghava GPS
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336658
[TBL] [Abstract][Full Text] [Related]
58. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
Giulietti M; Occhipinti G; Principato G; Piva F
Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
[TBL] [Abstract][Full Text] [Related]
59. Identification of lncRNAs Associated with Prognosis of Rectal Cancer by Comprehensive Bioinformatics Analysis Based on TCGA.
Wang C; Yuan G; Chen J
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710439
[TBL] [Abstract][Full Text] [Related]
60. [Prognosis-related miRNA bioinformatics screening of lung adenocarcinoma and its clinical significance].
Zhang HM; Yang B; Chen HF; Chi XH; Xi YB; Chen XM; Guo B; He PF; Lu XC
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jun; 34(6):530-535. PubMed ID: 31032588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]